InMed Pharmaceuticals Inc (INM) — Cash Flow-to-Debt Ratio
InMed Pharmaceuticals Inc (INM) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of $-1.76 Million could theoretically repay 0% of its total liabilities ($2.24 Billion) in one year. Check InMed Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
InMed Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for InMed Pharmaceuticals Inc across 25 annual periods. Also explore how large is InMed Pharmaceuticals Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for InMed Pharmaceuticals Inc (2001–2025)
Year-by-year debt coverage analysis for InMed Pharmaceuticals Inc. For market capitalisation and broader financial context, see INM market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.66x | $-7.77 Million | $2.92 Million | ▼ -36.1% |
| 2024 | -1.95x | $-6.99 Million | $3.58 Million | ▲ +28.4% |
| 2023 | -2.73x | $-7.28 Million | $2.67 Million | ▲ +16.5% |
| 2022 | -3.26x | $-15.58 Million | $4.78 Million | ▲ +0.9% |
| 2021 | -3.29x | $-9.79 Million | $2.97 Million | ▲ +14.1% |
| 2020 | -3.83x | $-7.37 Million | $1.92 Million | ▲ +31.7% |
| 2019 | -5.61x | $-6.68 Million | $1.19 Million | ▼ -8.8% |
| 2018 | -5.16x | $-3.68 Million | $713.02K | ▲ +38.0% |
| 2017 | -8.32x | $-2.37 Million | $284.24K | ▼ -883.3% |
| 2016 | -0.85x | $-386.07K | $456.17K | ▲ +96.7% |
| 2015 | -25.72x | $-1.61 Million | $62.51K | ▼ -181.1% |
| 2014 | -9.15x | $-641.38K | $70.11K | ▼ -1046.5% |
| 2013 | -0.80x | $-39.26K | $49.20K | ▲ +79.6% |
| 2012 | -3.92x | $-174.62K | $44.59K | ▲ +67.8% |
| 2011 | -12.16x | $-562.06K | $46.20K | ▼ -7854.5% |
| 2010 | -0.15x | $-195.42K | $1.28 Million | ▼ -260.5% |
| 2009 | 0.10x | $100.48K | $1.05 Million | ▲ +115.2% |
| 2008 | -0.63x | $-951.15K | $1.52 Million | ▲ +39.3% |
| 2007 | -1.03x | $-1.40 Million | $1.35 Million | ▼ -103.0% |
| 2006 | -0.51x | $-577.40K | $1.14 Million | ▼ -19.7% |
| 2005 | -0.42x | $-702.23K | $1.66 Million | ▲ +31.5% |
| 2004 | -0.62x | $-484.19K | $781.44K | ▲ +32.4% |
| 2003 | -0.92x | $-844.62K | $921.99K | ▲ +94.0% |
| 2002 | -15.36x | $-1.14 Million | $74.45K | ▼ -1505.2% |
| 2001 | -0.96x | $-471.69K | $493.02K | — |